BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25385620)

  • 1. Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.
    Takayama K; Morisaki Y; Kuno S; Nagamoto Y; Harada K; Furukawa N; Ohtaka M; Nishimura K; Imagawa K; Sakurai F; Tachibana M; Sumazaki R; Noguchi E; Nakanishi M; Hirata K; Kawabata K; Mizuguchi H
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16772-7. PubMed ID: 25385620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPα, and PROX1 transduction.
    Nakamori D; Takayama K; Nagamoto Y; Mitani S; Sakurai F; Tachibana M; Mizuguchi H
    Biochem Biophys Res Commun; 2016 Jan; 469(3):424-9. PubMed ID: 26679606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
    Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.
    Song Z; Cai J; Liu Y; Zhao D; Yong J; Duo S; Song X; Guo Y; Zhao Y; Qin H; Yin X; Wu C; Che J; Lu S; Ding M; Deng H
    Cell Res; 2009 Nov; 19(11):1233-42. PubMed ID: 19736565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance.
    Toba Y; Deguchi S; Mimura N; Sakamoto A; Harada K; Hirata K; Takayama K; Mizuguchi H
    PLoS One; 2020; 15(2):e0229654. PubMed ID: 32106262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.
    Javed MS; Yaqoob N; Iwamuro M; Kobayashi N; Fujiwara T
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):91-6. PubMed ID: 24491001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-dependent drug oxidation activities in commercially available hepatocytes derived from human induced pluripotent stem cells cultured for 3 weeks.
    Murayama N; Yamazaki H
    J Toxicol Sci; 2018; 43(4):241-245. PubMed ID: 29618712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient derivation of functional hepatocytes from mouse induced pluripotent stem cells by a combination of cytokines and sodium butyrate.
    Zhang Q; Yang Y; Zhang J; Wang GY; Liu W; Qiu DB; Hei ZQ; Ying QL; Chen GH
    Chin Med J (Engl); 2011 Nov; 124(22):3786-93. PubMed ID: 22340242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
    Nagamoto Y; Takayama K; Tashiro K; Tateno C; Sakurai F; Tachibana M; Kawabata K; Ikeda K; Tanaka Y; Mizuguchi H
    Cell Transplant; 2015; 24(6):1127-38. PubMed ID: 24806294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
    Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
    Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ESC/iPSC-Derived Hepatocyte-like Cells Achieve Zone-Specific Hepatic Properties by Modulation of WNT Signaling.
    Mitani S; Takayama K; Nagamoto Y; Imagawa K; Sakurai F; Tachibana M; Sumazaki R; Mizuguchi H
    Mol Ther; 2017 Jun; 25(6):1420-1433. PubMed ID: 28462819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
    Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection.
    Sakurai F; Mitani S; Yamamoto T; Takayama K; Tachibana M; Watashi K; Wakita T; Iijima S; Tanaka Y; Mizuguchi H
    Sci Rep; 2017 Apr; 7():45698. PubMed ID: 28374759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
    Mitani S
    Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Metabolizing Activity of Human ES Cell-Derived Hepatocytes Using a 3D Culture System with Repeated Exposures to Xenobiotics.
    Kim JH; Jang YJ; An SY; Son J; Lee J; Lee G; Park JY; Park HJ; Hwang DY; Kim JH; Han J
    Toxicol Sci; 2015 Sep; 147(1):190-206. PubMed ID: 26089346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
    Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
    Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.